Rimonabant



The daily-once drug, Rimonabant that reduces obesity is available in the market under the trade name Acomplia. It will be available via prescription only from today. It will cost £55.20 per month for a patient or £663 per year for a patient.



Rimonabant





The drug blocks brain’s activity that controls the energy balance and the break down of sugars and fats in the blood. That process results in less feeling of hunger.



The medicinal trials have already showed that forty percent of obese participants who took rimonabant lose ten percent weight of the body.



At the same time, the research also has found that the drug helps to decreases the concentration of damaging fatty deposits on the internal organs, which causes diabetes and heart disease.



Read